Ann C Collier

发表

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen

A. Collier, M. Fischl, P. Tebas, 2007, AIDS.

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

Jashvant D Unadkat, Evan D Kharasch, A. Collier, 2014, Biochemical pharmacology.

Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

Dominique Schols, M. Lederman, C. Flexner, 2004, Journal of acquired immune deficiency syndromes.

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

Lynne Peeples, David Katzenstein, Victoria A Johnson, 2009, The New England journal of medicine.

Antiretroviral-drug resistance among patients recently infected with HIV.

Elizabeth Connick, Richard A Koup, Lei Wang, 2002, The New England journal of medicine.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Susan Morgello, David Clifford, Florin Vaida, 2011, AIDS.

Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance

Susanne May, Christopher H Woelk, J. Margolick, 2008, AIDS.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Michael J Silverberg, Bryan Lau, Michael S Saag, 2009, The New England journal of medicine.

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.

Lawrence Corey, James I Mullins, Susan Moir, 2007, The Journal of infectious diseases.

A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy.

Heather Ribaudo, Judith Feinberg, M. Chesney, 2005, The Journal of infectious diseases.

The prevalence and incidence of neurocognitive impairment in the HAART era

Justin C McArthur, Thomas D Parsons, Ronald J Bosch, 2007, AIDS.

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

Anthony Gamst, Justin C McArthur, Ian Abramson, 2014, Neurology.

Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study

David A Mankoff, Janet F Eary, Jashvant D Unadkat, 2015, Drug Metabolism and Disposition.